Pfizer, Merck Pneumonia Shots Get Backing for Adults Over 50 (2)

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.

Members of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 14-to-1 to recommend all adults aged 50 and older get vaccinated to prevent the bacterial infections behind pneumonia and meningitis.

The group’s recommendation was endorsed by CDC Director Mandy Cohen. The CDC’s prior guidance for pneumococcal vaccines was for adults aged 65 and over and children ...